HY-1608

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameHY-1608
Drug Alias NameHY-1608HY1608
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNociceptin receptor agonistsMu opioid receptor agonists
TargetsNociceptin receptorMu opioid receptor
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Junke Huayuan Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Junke Huayuan Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A